Yposkesi develops gene therapies for the treatment of AAV and lentiviral vector. Read more

3 Followers on Owler
3 Followers on Owler
3 Followers on Owler
3 Followers on Owler

Yposkesi develops gene therapies for the treatment of AAV and lentiviral vector. Read more

Alain Lamproye's photo - Chairman & CEO of Yposkesi

Chairman & CEO

Alain Lamproye

CEO Approval Rating

90/100

Founded:

2016

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

IvexSol has been one of Yposkesi's top competitors. IvexSol's headquarters is in Worcester, Massachusetts, and was founded in 2019. Like Yposkesi, IvexSol also competes in the Biotechnology field. IvexSol generates 47% of Yposkesi's revenue.

Sirion-Biotech is one of Yposkesi's top rivals. Sirion-Biotech is a Private company that was founded in Martinsried, Bavaria in 2005. Like Yposkesi, Sirion-Biotech also works within the Biotechnology industry. Sirion-Biotech has 115 fewer employees vs. Yposkesi.

Synpromics is perceived as one of Yposkesi's biggest rivals. Synpromics was founded in 2010, and is headquartered in Midlothian, Scotland. Like Yposkesi, Synpromics also competes in the Biotechnology sector. Synpromics generates $117.9M more revenue vs. Yposkesi.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $2.1M a good estimate for Yposkesi's revenue?

Acquisitions

No recent acquisitions found related to Yposkesi

Yposkesi Funding History

No recent funding data found related to Yposkesi

Investments

No recent investments found related to Yposkesi

Yposkesi News

June 11, 2019BioPortfolio

Yposkesi signs with Servier to manufacture allogenic CART

Servier to work with Yposeski for the production of lentiviral vectors as the former works to develop... See more »
December 3, 2018Outsourcing-Pharma

Gene therapy manufacturing partnership to support 'booming' market

Axovant has signed a strategic partnership agreement with the CDMO Yposkesi to support its growing ge... See more »
November 30, 2018PharmaTech

Yposkesi Announces Agreement in Principle with Axovant to Expand Gene Therapy Manufacturing Capacity

Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement i... See more »

Social Media

Headquarters

26, rue Henri Auguste-Desbrueres

Corbeil-Essonnes, Île-de-France91100

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Yposkesi develops gene therapies for the treatment of AAV and lentiviral vector. Yposkesi was founded in 2016. Yposkesi's headquarters is located in Corbeil-Essonnes, Île-de-France, FR 91100. Yposkesi's Chairman & CEO, Alain Lamproye, currently has a...

CEO

Yposkesi's Chairman & CEO, Alain Lamproye, currently has an approval rating of 90%. Yposkesi's primary competitors are IvexSol, Sirion-Biotech & Synpromics.

Website

yposkesi.com

Frequently Asked Questions about Yposkesi

  1. When was Yposkesi founded?

    Yposkesi was founded in 2016
  2. Who is Yposkesi's CEO?

    Yposkesi's CEO is Alain Lamproye
  3. How much revenue does Yposkesi generate?

    Yposkesi generates $2.1M in revenue
  4. How much funding does Yposkesi have?

    Yposkesi has historically raised $0 in funding
  1. Where is Yposkesi's headquarters?

    Yposkesi's headquarters is in Corbeil-Essonnes Île-de-France, FR
  2. How many employees does Yposkesi have?

    Yposkesi has 150 employees
  3. What sector does Yposkesi operate in?

    Yposkesi is in Biotechnology
  4. Who are Yposkesi's competitors?

    Yposkesi's top competitors are IvexSol, Sirion-Biotech, Synpromics